The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
Network medicine framework for identifying drug-repurposing opportunities for COVID-19
Open accessAbstract
Significance: The COVID-19 pandemic has highlighted the importance of prioritizing approved drugs to treat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections. Here, we deployed algorithms relying on artificial intelligence, network diffusion, and network proximity to rank 6,340 drugs for their expected efficacy against SARS-CoV-2. We experimentally screened 918 drugs, allowing us to evaluate the performance of the existing drug-repurposing methodologies, and used a consensus algorithm to increase the accuracy of the predictions. Finally, we screened in human cells the top-ranked drugs, identifying six drugs that reduced viral infection, four of which could be repurposed to treat COVID-19. The developed strategy has significance beyond COVID-19, allowing us to identify drug-repurposing candidates for neglected diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This evaluation method aligns with the approach predominantly used in the literature12,14–16,18–20.”
From A foundation model for clinician-centered drug repurposing (2024) · cites this paper as [16]
Experimental — accuracy not yet measuredIn the citing paper
“The clinical utility of drug-repurposing artificial intelligence (AI) models remains limited because these models focus narrowly on diseases for which some drugs already exist.”
From A foundation model for clinician-centered drug repurposing (2024) · cites this paper as [16]
In the citing paper
“Unfortunately, the ability of existing machine learning models to identify therapeutic candidates for diseases with incomplete, sparse data and zero-known therapies drops drastically16,22 (as we demonstrate across eight benchmarks in Fig. 2c,d).”
From A foundation model for clinician-centered drug repurposing (2024) · cites this paper as [16]
In the citing paper
“To provide therapeutic predictions, geometric deep-learning models optimized on large medical KGs15 can match disease signatures to therapeutic candidates based on networks perturbed in disease15–18.”
From A foundation model for clinician-centered drug repurposing (2024) · cites this paper as [16]
In the citing paper
“Graph representation learning has been successful in characterizing drugs at the systems level without patient data to make predictions about interactions with other drugs, protein targets, side effects, diseases [6, 38, 39, 40, 48, 165].”
From Graph representation learning in biomedicine and healthcare (2022) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adam: A Method for Stochastic Optimization
Kingma, D. P., & Ba, J. (2014) · arXiv · doi:10.48550/arxiv.1412.6980 · Cited by 98,946
Scikit-learn: Machine Learning in Python
Pedregosa, F., Varoquaux, G., Gramfort, A., Michel, V., Thirion, B., Grisel, O., Blondel, M., Müller, A., Nothman, J., Louppe, G., et al. (2012) · arXiv · doi:10.48550/arxiv.1201.0490 · Cited by 71,016
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
(2014) · Cited by 33,419
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Graph Attention NetworksPreprint
Veličković, P., Casanova, A., Liò, P., Cucurull, G., Romero, A., & Bengio, Y. (2017) · arXiv (Cornell University) · doi:10.17863/cam.48429 · Cited by 19,745
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
(2010) · Cited by 14,134
Cited by
Sorted by citations
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Scientific discovery in the age of artificial intelligence.
Wang, H., Fu, T., Du, Y., Gao, W., Huang, K., Liu, Z., Chandak, P., Liu, S., Van Katwyk, P., Deac, A., et al. (2023) · Nature · doi:10.1038/s41586-023-06221-2 · Cited by 1,823
Artificial intelligence in COVID-19 drug repurposing
Zhou, Y., Wang, F., Tang, J., Nussinov, R., & Cheng, F. (2020) · The Lancet Digital Health · doi:10.1016/s2589-7500(20)30192-8 · Cited by 636
Building a knowledge graph to enable precision medicine
Chandak, P., Huang, K., & Zitnik, M. (2023) · Scientific Data · doi:10.1038/s41597-023-01960-3 · Cited by 522
Self-citationCOVID-19 and Cardiovascular Disease
Chung, M. K., Zidar, D. A., Bristow, M. R., Cameron, S. J., Chan, T. A.-T., Harding, C. V., Kwon, D. H., Singh, T. K., Tilton, J. C., Tsai, E. J., et al. (2021) · Circulation Research · doi:10.1161/circresaha.121.317997 · Cited by 377
Self-citationUtilizing graph machine learning within drug discovery and development
Gaudelet, T., Day, B., Jamasb, A. R., Soman, J., Regep, C., Liu, G., Hayter, J. B. R., Vickers, R., Roberts, C., Tang, J., et al. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab159 · Cited by 313
Graph representation learning in biomedicine and healthcare
Li, M. M., Huang, K., & Zitnik, M. (2022) · Nature Biomedical Engineering · doi:10.1038/s41551-022-00942-x · Cited by 294
“Graph theoretic techniques have fuelled many discoveries, from uncovering relationships between diseases 43–46 to repurposing drugs 6,47,48 .”
Self-citationLeveraging Data Science to Combat COVID-19: A Comprehensive Review
Latif, S., Usman, M., Manzoor, S., Iqbal, W., Qadir, J., Gareth Tyson, A., Castro, I., Razi, A., Boulos, M. N. K., Weller, A., et al. (2020) · IEEE Transactions on Artificial Intelligence · doi:10.1109/tai.2020.3020521 · Cited by 273
A foundation model for clinician-centered drug repurposing
Huang, K., Chandak, P., Wang, Q., Havaldar, S., Vaid, A., Leskovec, J., Nadkarni, G. N., Glicksberg, B. S., Gehlenborg, N., & Zitnik, M. (2024) · Nature Medicine · doi:10.1038/s41591-024-03233-x · Cited by 249
“These label-efficient and clinician-centered learning systems pave the way for improvements for many therapeutic tasks.”
BackgroundApplications of artificial intelligence in battling against covid-19: A literature review
Tayarani N., M.-H. (2021) · Chaos, Solitons & Fractals · doi:10.1016/j.chaos.2020.110338 · Cited by 210
Drug repurposing for COVID-19 via knowledge graph completion
Zhang, R., Hristovski, D., Schutte, D., Kastrin, A., Marcelo Fiszman, B., & Halil Kilicoglu, B. (2021) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2021.103696 · Cited by 237
Artificial intelligence foundation for therapeutic science
Huang, K., Fu, T., Gao, W., Zhao, Y., Roohani, Y., Leskovec, J., Coley, C. W., Xiao, C., Sun, J., & Zitnik, M. (2022) · Nature Chemical Biology · doi:10.1038/s41589-022-01131-2 · Cited by 207
SumGNN: multi-typed drug interaction prediction via efficient knowledge graph summarization
Yu, Y., Huang, K., Zhang, C., Glass, L. M., Sun, J., & Xiao, C. (2021) · Bioinformatics · doi:10.1093/bioinformatics/btab207 · Cited by 207
Deep learning for drug repurposing: Methods, databases, and applications
Pan, X., Lin, X., Cao, D., Zeng, X., Yu, P. S., He, L., Nussinov, R., & Cheng, F. (2022) · Wiley Interdisciplinary Reviews Computational Molecular Science · doi:10.1002/wcms.1597 · Cited by 202
Zhou, Y., Hou, Y., Shen, J., Mehra, R., Kallianpur, A., Culver, D. A., Gack, M. U., Farha, S., Zein, J., Comhair, S., et al. (2020) · PLoS Biology · doi:10.1371/journal.pbio.3000970 · Cited by 180
Evaluating explainability for graph neural networks
Agarwal, C., Queen, O., Lakkaraju, H., & Zitnik, M. (2023) · Scientific Data · doi:10.1038/s41597-023-01974-x · Cited by 186
Self-citationExploring the SARS-CoV-2 virus-host-drug interactome for drug repurposing
Sadegh, S., Matschinske, J., Blumenthal, D. B., Galindez, G., Kacprowski, T., List, M., Nasirigerdeh, R., Oubounyt, M., Pichlmair, A., Rose, T. D., et al. (2020) · RePEc: Research Papers in Economics · Cited by 176
Exploring the SARS-CoV-2 virus-host-drug interactome for drug repurposing
Sadegh, S., Matschinske, J., Blumenthal, D. B., Galindez, G., Kacprowski, T., List, M., Nasirigerdeh, R., Oubounyt, M., Pichlmair, A., Rose, T. D., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17189-2 · Cited by 182
Drug repurposing for COVID-19: Approaches, challenges and promising candidates
Ng, Y. L., Salim, C. K., & Chu, J. J. H. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107930 · Cited by 158
Digital Twins in Healthcare: Methodological Challenges and Opportunities
Meijer, C., Uh, H., & el Bouhaddani, S. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13101522 · Cited by 122
Lessons from the COVID-19 pandemic for advancing computational drug repurposing strategies
Galindez, G., Matschinske, J., Rose, T. D., Sadegh, S., Salgado-Albarrán, M., Späth, J., Baumbach, J., & Pauling, J. K. (2021) · Nature Computational Science · doi:10.1038/s43588-020-00007-6 · Cited by 123
Current Strategies of Antiviral Drug Discovery for COVID-19
Mei, M., & Tan, X. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.671263 · Cited by 111
Lv, H., Shi, L., Berkenpas, J. W., Dao, F.-Y., Zulfiqar, H., Ding, H., Zhang, Y., Yang, L., & Cao, R. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab320 · Cited by 107
SAveRUNNER: A network-based algorithm for drug repurposing and its application to COVID-19
Fiscon, G., Conte, F., Farina, L., & Paci, P. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1008686 · Cited by 108
Computational drug repurposing: approaches, evaluation of in silico resources and case studies
Tanoli, Z., Fernández‐Torras, A., Özcan, U. O., Kushnir, A., Nader, K. M., Gadiya, Y., Fiorenza, L., Ianevski, A., Vähä-Koskela, M. J. V., Miihkinen, M., et al. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01164-x · Cited by 104
Extending the Nested Model for User-Centric XAI: A Design Study on GNN-based Drug Repurposing
Wang, Q., Huang, K., Chandak, P., Zitnik, M., & Gehlenborg, N. (2023) · IEEE Transactions on Visualization and Computer Graphics · doi:10.1109/tvcg.2022.3209435 · Cited by 82
Self-citationAccelerating science with human-aware artificial intelligence
Sourati, J., & Evans, J. A. (2023) · Nature Human Behaviour · doi:10.1038/s41562-023-01648-z · Cited by 94
Nursing homes and the elderly regarding the COVID-19 pandemic: situation report from Hungary
Kemenesi, G., Kornya, L., Tóth, G. E., Kurucz, K., Zeghbib, S., Somogyi, B. A., Zöldi, V., Urban, P. P., Herczeg, R., & Jakab, F. (2020) · GeroScience · doi:10.1007/s11357-020-00195-z · Cited by 78
Contextual AI models for single-cell protein biology
Li, M. M., Huang, Y., Sumathipala, M. G., Liang, M. Q., Valdeolivas, A., Ananthakrishnan, A. N., Liao, K. P., Marbach, D., & Žitnik, M. (2024) · Nature Methods · doi:10.1038/s41592-024-02341-3 · Cited by 85
SAveRUNNER: an R-based tool for drug repurposing
Fiscon, G., & Paci, P. (2021) · BMC Bioinformatics · doi:10.1186/s12859-021-04076-w · Cited by 78
Host metabolic reprogramming in response to SARS-CoV-2 infection: A systems biology approach
Moolamalla, S. T. R., Balasubramanian, R., Chauhan, R., Priyakumar, U. D., & Vinod, P. K. U. (2021) · Microbial Pathogenesis · doi:10.1016/j.micpath.2021.105114 · Cited by 82
Deep learning in target prediction and drug repositioning: Recent advances and challenges
Yu, J., Dai, Q.-Q., & Li, G. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.10.010 · Cited by 74
Wang, X., Cheng, Y., Yang, Y., Yu, Y., Li, F., & Peng, S. (2023) · Nature Machine Intelligence · doi:10.1038/s42256-023-00640-6 · Cited by 77
Automated Machine Learning on Graphs: A Survey
Zhang, Z., Wang, X., & Zhu, W. (2021) · International Joint Conference on Artificial Intelligence · doi:10.24963/ijcai.2021/637 · Cited by 89
Artigas, L., Coma, M., Matos‐Filipe, P., Aguirre‐Plans, J., Farrés, J., Valls, R., Fernández‐Fuentes, N., de la Haba-Rodríguez, J., Olvera, À., Barberá, J. M., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0240149 · Cited by 67
Application of artificial intelligence in COVID-19 medical area: a systematic review
Chang, Z., Zhan, Z., Zhao, Z., You, Z., Liu, Y., Yan, Z., Fu, Y., Liang, W., & Zhao, L. (2021) · Journal of Thoracic Disease · doi:10.21037/jtd-21-747 · Cited by 64
Antimicrobial Properties of Antidepressants and Antipsychotics—Possibilities and Implications
Caldara, M., & Marmiroli, N. (2021) · Pharmaceuticals · doi:10.3390/ph14090915 · Cited by 54
Revolutionizing Vaccine Development for COVID-19: A Review of AI-Based Approaches
Ghosh, A., Larrondo-Petrie, M. M., & Pavlović, M. D. (2023) · Information · doi:10.3390/info14120665 · Cited by 51
Artificial intelligence for COVID-19: battling the pandemic with computational intelligence
Xu, Z., Su, C., Xiao, Y., & Wang, F. (2021) · Intelligent Medicine · doi:10.1016/j.imed.2021.09.001 · Cited by 48
Target Discovery for Host-Directed Antiviral Therapies: Application of Proteomics Approaches
Çakır, M., Obernier, K., Forget, A., & Krogan, N. J. (2021) · mSystems · doi:10.1128/msystems.00388-21 · Cited by 45
Gao, K., Song, Y., & Song, A. (2020) · BioData Mining · doi:10.1186/s13040-020-00229-4 · Cited by 40
Network machine learning maps phytochemically rich “Hyperfoods” to fight COVID-19
Laponogov, I., Gonzalez, G., Shepherd, M., Qureshi, A., Veselkov, D. A., Charkoftaki, G., Vasiliou, V., Youssef, J., Mirnezami, R., Bronstein, M. M., et al. (2021) · Human Genomics · doi:10.1186/s40246-020-00297-x · Cited by 40
Zhang, L., Fan, S., Vera, J., & Lai, X. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.11.037 · Cited by 37
Gupta, C., Xu, J., Jin, T., Khullar, S., Liu, X., Alatkar, S., Cheng, F., & Wang, D. (2022) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1010287 · Cited by 33
Contrastive learning improves critical event prediction in COVID-19 patients
Wanyan, T., Honarvar, H., Jaladanki, S. K., Zang, C., Naik, N., Somani, S. S., Freitas, J. K. D., Paranjpe, I., Vaid, A., Zhang, J., et al. (2021) · Patterns · doi:10.1016/j.patter.2021.100389 · Cited by 34
Knowledge Graphs for COVID-19: An Exploratory Review of the Current Landscape
Chatterjee, A., Nardi, C., Oberije, C., & Lambin, P. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11040300 · Cited by 33
Explainable drug repurposing via path based knowledge graph completion
Jiménez, A., Merino, M. J., Parras, J., & Zazo, S. (2024) · Scientific Reports · doi:10.1038/s41598-024-67163-x · Cited by 30
Drug2ways: Reasoning over causal paths in biological networks for drug discovery
Rivas-Barragan, D., Mubeen, S., Guim, F., Hofmann‐Apitius, M., & Domingo‐Fernándéz, D. (2020) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1008464 · Cited by 28
In silico drug repurposing in COVID-19: A network-based analysis
Sibilio, P., Bini, S., Fiscon, G., Sponziello, M., Conte, F., Pecce, V., Durante, C., Paci, P., Falcone, R., Norata, G. D., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111954 · Cited by 30
Clerbaux, L., Albertini, M. C., Amigó, N., Beronius, A., Bezemer, G. F. G., Coecke, S., Daskalopoulos, E. P., del Giudice, G., Greco, D., Grenga, L., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11154464 · Cited by 30
Ghavasieh, A., Bontorin, S., Artime, O., Verstraete, N., & Domenico, M. D. (2021) · Communications Physics · doi:10.1038/s42005-021-00582-8 · Cited by 28
Gupta, R. K., Nwachuku, E. L., Zusman, B. E., Jha, R. M., & Puccio, A. M. (2021) · PLoS ONE · doi:10.1371/journal.pone.0257784 · Cited by 27
A modular framework for the development of targeted Covid-19 blood transcript profiling panels
Rinchai, D., Kabeer, B. S. A., Toufiq, M., Tatari-Calderone, Z., Deola, S., Brummaier, T., Garand, M., Branco, R. G., Baldwin, N. E., Alfaki, M., et al. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02456-z · Cited by 26
Biological Insights Knowledge Graph: an integrated knowledge graph to support drug developmentPreprint
Geleta, D., Nikolov, A., Edwards, G., Gogleva, A. A., Jackson, R., Jansson, E., Lamov, A., Nilsson, S., Pettersson, M., Poroshin, V., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.28.466262 · Cited by 25
Wang, H., Zhang, J., Lu, Z., Dai, W., Ma, C., Xiang, Y., & Zhang, Y. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab373 · Cited by 23
Hsieh, K., Plascencia‐Villa, G., Lin, K., Perry, G. L., Jiang, X., & Kim, Y. (2022) · iScience · doi:10.1016/j.isci.2022.105678 · Cited by 24
A data-driven methodology towards evaluating the potential of drug repurposing hypotheses
Santamaría, L. P., Carro, E. U., Uzquiano, M. D., Menasalvas, E., Gallardo, Y. P., & Rodríguez‐González, A. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.08.003 · Cited by 26
Cascading from SARS-CoV-2 to Parkinson’s Disease through Protein-Protein Interactions
Estrada, E. (2021) · Viruses · doi:10.3390/v13050897 · Cited by 21
Analyzing knowledge entities about COVID-19 using entitymetrics
Qi, Y., Wang, Q., Zhang, Y., Chen, C., Ryu, H., Park, N., Baek, J.-E., Li, K., Wu, Y., Li, D., et al. (2021) · Scientometrics · doi:10.1007/s11192-021-03933-y · Cited by 22
Enhancing foundation models for scientific discovery via multimodal knowledge graph representations
López, V., Hoang, L. T., Galindo, M. M., Fernández-Díaz, R., Sbodio, M. L., Ordóñez-Hurtado, R., Zayats, M., Mulligan, N., & Bettencourt‐Silva, J. H. (2024) · Journal of Web Semantics · doi:10.1016/j.websem.2024.100845 · Cited by 22
Schultz, B. T., Zaliani, A., Ebeling, C., Reinshagen, J., Bojková, D., Lage‐Rupprecht, V., Karki, R., Lukassen, S., Gadiya, Y., Ravindra, N. G., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-90296-2 · Cited by 19
Fractional diffusion on the human proteome as an alternative to the multi-organ damage of SARS-CoV-2
Estrada, E. (2020) · Chaos An Interdisciplinary Journal of Nonlinear Science · doi:10.1063/5.0015626 · Cited by 20
Fighting COVID-19 with Artificial Intelligence
Monteleone, S., Kellici, T. F., Southey, M., Bodkin, M. J., & Heifetz, A. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-1787-8_3 · Cited by 17
Desvaux, E., Hamon, A., Hubert, S., Boudjeniba, C., Chassagnol, B., Swindle, J., Aussy, A., Laigle, L., Laplume, J., Soret, P., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0254374 · Cited by 18
Drug repositioning by merging active subnetworks validated in cancer and COVID-19
Lucchetta, M., & Pellegrini, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-99399-2 · Cited by 15
Domingo‐Fernándéz, D., Gadiya, Y., Patel, A., Mubeen, S., Rivas-Barragan, D., Diana, C. W., Misra, B. B., Healey, D., Rokicki, J., & Colluru, V. (2022) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1009909 · Cited by 15
Tang, A., Woldemariam, S. R., Roger, J. M., & Sirota, M. (2022) · Yearbook of Medical Informatics · doi:10.1055/s-0042-1742513 · Cited by 16
Sperry, M. M., Oskotsky, T., Marić, I., Kaushal, S., Takeda, T., Horváth, V., Powers, R. K., Rodas, M. J., Furlong, B. A., Soong, M., et al. (2023) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1011050 · Cited by 15
Integration of Multi-Omics Data
Savitha, S., Keerthana, R., Logeswaran, K., Keerthika, P., Sharmila, V., & Sangeetha, M. (2025) · Advances in computational intelligence and robotics book series · doi:10.4018/979-8-3693-9521-9.ch006 · Cited by 18
Barsi, S., Papp, H., Valdeolivas, A., Tóth, D. J., Kuczmog, A., Madai, M., Hunyady, L., Várnai, P., Sáez-Rodríguez, J., Jakab, F., et al. (2022) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1010021 · Cited by 12
Treveil, A., Bohár, B., Sudhakar, P., Gul, L., Csabai, L., Olbei, M. L., Poletti, M., Madgwick, M., Andrighetti, T., Hautefort, I., et al. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1008685 · Cited by 11
Major Insights in Dynamics of Host Response to SARS-CoV-2: Impacts and Challenges
Hakim, A., Hasan, M. M., Hasan, M., Lokman, S. M., Azim, K. F., Raihan, T., Chowdhury, P. A., & Azad, A. K. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.637554 · Cited by 13
Das, A. B. (2021) · BMC Medical Genomics · doi:10.1186/s12920-021-01079-7 · Cited by 12
Krämer, A., Billaud, J.-N., Tugendreich, S., Shiffman, D., Jones, M., & Green, J. (2021) · BMC Bioinformatics · doi:10.1186/s12859-021-04148-x · Cited by 11
Khojasteh, H., Khanteymoori, A., & Olyaee, M. H. (2022) · Scientific Reports · doi:10.1038/s41598-022-08574-6 · Cited by 11
Kaur, H., Sarma, P., Bhattacharyya, A., Prajapat, M., Kumar, S., Prakash, A., & Medhi, B. (2021) · Medical Hypotheses · doi:10.1016/j.mehy.2021.110539 · Cited by 10
Optimal COVID-19 therapeutic candidate discovery using the CANDO platform
Mangione, W., Falls, Z., & Samudrala, R. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.970494 · Cited by 9
Molecular targets and system biology approaches for drug repurposing against SARS-CoV-2
SINGH, R. K., Yadav, B. S., & Mohapatra, T. M. (2020) · Bulletin of the National Research Centre/Bulletin of the National Research Center · doi:10.1186/s42269-020-00444-3 · Cited by 10
Dynamic changes in gene-to-gene regulatory networks in response to SARS-CoV-2 infection
Tanaka, Y., Higashihara, K., Nakazawa, M. A., Yamashita, F., Tamada, Y., & Okuno, Y. (2021) · Scientific Reports · doi:10.1038/s41598-021-90556-1 · Cited by 10
Zambrana, C., Xenos, A., Böttcher, R., Malod‐Dognin, N., & Pržulj, N. (2021) · Scientific Reports · doi:10.1038/s41598-021-98289-x · Cited by 10
Patten, J. J., Keiser, P. T., Gysi, D. M., Menichetti, G., Mori, H., Donahue, C. J., Gan, X., do Valle, Í. F., Geoghegan-Barek, K. M., Anantpadma, M., et al. (2022) · SSRN Electronic Journal · doi:10.1101/2021.04.20.440626 · Cited by 10
Self-citationAzad, A., Fatima, S., Capraro, A., Waters, S. A., & Vafaee, F. (2021) · Patterns · doi:10.1016/j.patter.2021.100325 · Cited by 9
Menestrina, L., Cabrelle, C., & Recanatini, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-98812-0 · Cited by 9
Rivero-García, I., Castresana-Aguirre, M., Guglielmo, L., Guala, D., & Sonnhammer, E. L. L. (2021) · Scientific Reports · doi:10.1038/s41598-021-99721-y · Cited by 9
Tong, Y., Li, X., Wan, J., Zhou, Q. X., Jiang, C., Li, N., Jin, Z., Gu, J., Li, F., & Li, J. (2025) · Journal of Separation Science · doi:10.1002/jssc.70072 · Cited by 8
Lucchetta, M., & Pellegrini, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-74705-6 · Cited by 9
The peripheral and core regions of virus-host network of COVID-19
Wang, B., Dong, X., Hu, J., Ma, X., Han, C., Wang, Y., & Gao, L. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab169 · Cited by 8
Li, Y., Shen, Y. L., Cai, Y., Zhang, Y., Gao, J., Huang, L. F., Si, W., Zhou, K., Gao, S., & Luo, Q. (2025) · Scientific Reports · doi:10.1038/s41598-024-82498-1 · Cited by 7
Network Biology and Medicine to Rescue: Applications for Retinal Disease Mechanisms and Therapy
Mondal, A. K., & Swaroop, A. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-27681-1_25 · Cited by 7
Lee, H. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.11.07.467640 · Cited by 7
Structure learning for gene regulatory networks
Federico, A. N., Kern, J. G., Varelas, X., & Monti, S. (2023) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1011118 · Cited by 6
Nayak, S. S., Naidu, A., Sajitha Lulu, S., Sundararajan, V., & Selvaraj, G. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13040664 · Cited by 6
Astore, C., Zhou, H., Jacob, J., & Skolnick, J. (2021) · Scientific Reports · doi:10.1038/s41598-021-00368-6 · Cited by 6
Xu, Z., Chan, C. S., Zhang, Q., Xu, Y., He, L., Cheung, F., Yang, J., Chan, E., Fung, J., Tsang, C., et al. (2022) · Communications Medicine · doi:10.1038/s43856-022-00222-4 · Cited by 6
Konrat, R., Papp, H., Szijártó, V., Gesell, T., Nagy, G., Madai, M., Zeghbib, S., Kuczmog, A., Lanszki, Z., Helyes, Z., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.09.15.296228 · Cited by 6
Williams, A. H., & Zhan, C. (2023) · BioDrugs · doi:10.1007/s40259-023-00611-8 · Cited by 5
Li, M., Zhang, G., Tang, Q., Xi, K., Lin, Y., & Chen, W. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.108292 · Cited by 4
Protein–Protein Interaction Network for the Identification of New Targets Against Novel Coronavirus
Kumar, S. (2021) · Methods in pharmacology and toxicology · doi:10.1007/7653_2020_62 · Cited by 5
Big Data Analytics for Modeling COVID-19 and Comorbidities: An Unmet Need
Shakyawar, S. K., Sethi, S., Southekal, S., Mishra, N. K., & Guda, C. (2021) · EAI/Springer Innovations in Communication and Computing · doi:10.1007/978-3-030-68936-0_10 · Cited by 4
Metadata
- Authors
- Morselli Gysi, D., do Valle, Í., Zitnik, M., Ameli, A., Gan, X., Varol, O., Ghiassian, S. D., Patten, J. J., Davey, R. A., Loscalzo, J., & Barabási, A.-L.
- Affiliations
- Network Science Institute, Northeastern University, Boston, MA 02115;
- Department of Biomedical Informatics, Harvard University, Boston, MA 02115;
- Northeastern University (US)
- Brigham and Women's Hospital (US)
- Data Science Department, Scipher Medicine, Waltham, MA 02453;
- Boston University (US)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2021-04-27
- Volume
- 118
- Issue
- 19
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W3017271475
- Cited by
- 107
- References
- 100
- Citations by year
- 2025: 5 · 2024: 6 · 2023: 16 · 2022: 15 · 2021: 47
- FWCI
- 11.07
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion, cc-by)
- PubMed (publishedVersion)
- arXiv (Cornell University) (submittedVersion)
- Europe PMC (PubMed Central) (submittedVersion, cc-by-nc-sa)
- Sabanci University (submittedVersion)
- Open Research (Auckland University of Technology) (submittedVersion, cc-by)
- arXiv (Cornell University)
- Funders
- American Heart Association
- National Institutes of Health (HL 108630)
- National Heart, Lung, and Blood Institute (P01HL132825, R01HL155096, U54HL119145, U01HL108630, R01HL155107)
- National Human Genome Research Institute (U01HG007690)
- National Institute of Allergy and Infectious Diseases (R01AI128364, R01AI125453, P01AI120943, UC7AI095321)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
- Keywords
- COVID-19 pandemic, SARS-CoV-2, drug repurposing, network medicine, drug prioritization, network diffusion, network proximity, consensus forecasts, antiviral drug discovery, neglected diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
